Personalized medicine: Time for one-person trials

Nature. 2015 Apr 30;520(7549):609-11. doi: 10.1038/520609a.
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized / pharmacology
  • Benzamides / pharmacology
  • Biomarkers / analysis
  • Cetuximab
  • Clinical Trials as Topic / methods*
  • Clinical Trials as Topic / trends*
  • Humans
  • Imatinib Mesylate
  • Indoles / pharmacology
  • Pharmacogenetics / trends
  • Piperazines / pharmacology
  • Precision Medicine / methods*
  • Precision Medicine / trends*
  • Pyrimidines / pharmacology
  • Research Design*
  • Sample Size
  • Sulfonamides / pharmacology
  • Vemurafenib

Substances

  • Antibodies, Monoclonal, Humanized
  • Benzamides
  • Biomarkers
  • Indoles
  • Piperazines
  • Pyrimidines
  • Sulfonamides
  • Vemurafenib
  • Imatinib Mesylate
  • Cetuximab